Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China; The Key laboratory of Anti-inflammatory and Immune medicines, Ministry of Education Hefei, China; Institute for Liver Diseases of Anhui Medical University, Hefei, China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China; The Key laboratory of Anti-inflammatory and Immune medicines, Ministry of Education Hefei, China; Institute for Liver Diseases of Anhui Medical University, Hefei, China.
Int Immunopharmacol. 2019 Oct;75:105765. doi: 10.1016/j.intimp.2019.105765. Epub 2019 Jul 20.
Hepatic fibrosis is the most common pathological feature of most chronic liver diseases, and its continuous deterioration gradually develops into liver cirrhosis and eventually leads to liver cancer. At present, there are many kinds of drugs used to treat liver fibrosis. However, Western drugs tend to only target single genes/proteins and induce many adverse reactions. Most of the mechanisms and active ingredients of traditional Chinese medicine (TCM) are not clear, and there is a lack of unified diagnosis and treatment standards. Natural products, which are characterized by structural diversity, low toxicity, and origination from a wide range of sources, have unique advantages and great potential in anti-liver fibrosis. This article summarizes the work done over the previous decade, on the active ingredients in natural products that are reported to have anti-hepatic fibrosis effects. The effective anti-hepatic fibrosis ingredients identified can be generally divided into flavonoids, saponins, polysaccharides and alkaloids. Mechanisms of anti-liver fibrosis include inhibition of liver inflammation, anti-lipid peroxidation injury, inhibition of the activation and proliferation of hepatic stellate cells (HSCs), modulation of the synthesis and secretion of pro-fibrosis factors, and regulation of the synthesis and degradation of the extracellular matrix (ECM). This review provides suggestions for the development of anti-hepatic fibrosis drugs.
肝纤维化是大多数慢性肝病最常见的病理特征,其持续恶化逐渐发展为肝硬化,最终导致肝癌。目前,有许多种药物可用于治疗肝纤维化。然而,西药往往只针对单个基因/蛋白,引起许多不良反应。中药(TCM)的大多数机制和活性成分尚不清楚,缺乏统一的诊断和治疗标准。天然产物以结构多样性、低毒性和广泛的来源为特征,在抗肝纤维化方面具有独特的优势和巨大的潜力。本文总结了过去十年在具有抗肝纤维化作用的天然产物活性成分方面所做的工作。已鉴定出的有效抗肝纤维化成分一般可分为黄酮类、皂苷类、多糖类和生物碱类。抗肝纤维化的机制包括抑制肝炎症、抗脂质过氧化损伤、抑制肝星状细胞(HSCs)的激活和增殖、调节促纤维化因子的合成和分泌以及调节细胞外基质(ECM)的合成和降解。这篇综述为抗肝纤维化药物的开发提供了建议。